Oliver Keil

USPTO Granted Patents = 13 (Patent Applications = 10)

CIPO Patents = 6 (Patent Applications = 6)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 54(Granted Patents)

Location History:

Glienicke/Nordbahn, DE (2011 - 2015)
Glienicke, DE (2012 - 2016)
Heidelberg, DE (2017 - 2020)
Berlin, DE (2018 - 2021)

Company Filing History:

Silence Therapeutics Gmbh

patents

2 out of 5

Silence Therapeutics Ag

patents

4. 1 out of 1

Silence Therpeutics Ag

patent

Years Active: 2011-2021

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10980860 - Diagnosis, prevention and treatment of diseases of the joint (2021-04-20),

2. 10729778 - Carrier-linked treprostinil prodrugs (2020-08-04),

3. 9913912 - Carrier-linked prostanoid prodrugs (2018-03-13),

4. 9872864 - Sustained release composition of prostacyclin (2018-01-23),

5. 9561287 - Carrier-linked treprostinil prodrugs (2017-02-07),

6. 9486538 - Lipids, lipid complexes and use thereof (2016-11-08),

7. 9387262 - Coated lipid complexes and their use (2016-07-12),

8. 9125820 - Lipids, lipid complexes and use thereof (2015-09-08),

9. 8852472 - Coated lipid complexes and their use (2014-10-07),

10. 8735453 - Lipids, lipid complexes and use thereof (2014-05-27),

11. 8357722 - Lipids, lipid complexes and use thereof (2013-01-22),

12. 8232256 - Means for inhibiting the expression of protein kinase 3 (2012-07-31),

13. 8017804 - Lipids, lipid complexes and use thereof (2011-09-13),

Title: The Innovative Contributions of Oliver Keil

Introduction

Oliver Keil is a prominent inventor based in Glienicke, Germany. He has made significant contributions to the field of medical technology, particularly in the treatment and diagnosis of joint diseases. With a total of 13 patents to his name, Keil's work has had a substantial impact on healthcare.

Latest Patents

Among his latest patents is a groundbreaking invention focused on the diagnosis, prevention, and treatment of diseases of the joint. This invention relates to a polymeric prodrug designed for use in treating, preventing, and diagnosing joint diseases, along with pharmaceutical compositions and medical devices that incorporate these polymeric prodrugs. Another notable patent is for carrier-linked treprostinil prodrugs, which are prodrugs or pharmaceutically acceptable salts that include a covalent treprostinil carrier conjugate. These prodrugs can be utilized as medicaments, particularly for conditions treatable by treprostinil, such as pulmonary arterial hypertension (PAH).

Career Highlights

Throughout his career, Oliver Keil has worked with several notable companies, including Ascendis Pharma A/S and Silence Therapeutics GmbH. His innovative work in these organizations has contributed to advancements in medical treatments and technologies.

Collaborations

Keil has collaborated with esteemed colleagues, including Jörg Kaufmann and Ulrich Hersel. These partnerships have fostered a collaborative environment that encourages innovation and the development of new medical solutions.

Conclusion

Oliver Keil's contributions to the field of medical technology through his patents and collaborations highlight his role as a leading inventor. His work continues to influence the treatment and diagnosis of various medical conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.